LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis -

Aplikace | 2017 | ShimadzuInstrumentace

LC/MS, LC/MS/MS, LC/QQQ

Zaměření

Farmaceutická analýza

Výrobce

Shimadzu

Přejít do knihovny Zobrazit PDF

PDF verze ke stažení a čtení

Podobná PDF

LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis -

2017|Shimadzu|Aplikace

LAAN-A-LM-E118A Application News No. C147A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that…

Klíčová slova

nivolumab, nsmol, antibody, structure, nsmoltm, accuracy, peptides, confirmation, immunological, drugs, validation, average, quantitation, immune, bioanalysis

LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis -

2017|Shimadzu|Aplikace

LAAN-A-LM-E116B Application News No. C145B nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables selective proteolysis…